Max Robotics — Global Service Robot Directory + US Certification

About

Mary Ann Wertan is a pioneering cardiac surgeon whose research focuses on advancing minimally invasive coronary revascularization techniques, particularly robotic-assisted surgery. Her work addresses a critical gap in cardiac care: providing the "gold standard" left internal thoracic artery (LITA) to left anterior descending artery (LAD) anastomosis to patients who are not candidates for traditional coronary artery bypass grafting (CABG) and are only amenable to percutaneous coronary intervention (PCI) with stents. Her most-cited paper, "Long-term clinical outcomes of robotic-assisted surgical coronary artery revascularisation" (2023, 15 citations), demonstrates the durability and efficacy of this innovative approach. Expanding on this foundation, her 2024 study on "Midterm Clinical Outcomes of Robotic-Assisted Reverse Hybrid Coronary Revascularization" (4 citations) explores a novel hybrid strategy combining robotic surgery with PCI, offering new hope for complex patients. Wertan's contributions are reshaping the landscape of coronary revascularization, pushing the boundaries of what is possible with robotic technology. Her work not only improves patient outcomes but also expands surgical options for those previously deemed high-risk, establishing her as a key figure in the evolution of cardiac surgery.